2025 Market Reports Update: Forecasts Through 2034, Emerging Trends, Key Players, and Leading Regions – Stay Ahead of the Competition Today!
Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.
How Did the Diabetes Diagnostics Industry Size Grow in the Last 5 Years?
The market size of diabetes diagnostics has been increasing robustly over the past years. The market, starting from $25.39 billion in 2024, is projected to boost to $27.39 billion in 2025, encountering a compound annual growth rate (CAGR) of 7.9%. This augmentation during the historic timeline can be ascribed to the persistent rise in diabetes cases, the expansion of the elderly population, escalation in sedentary ways of living, growth in acceptance of minimally invasive diagnostics, and the increasing occurrence of obesity.
Download Your Free Diabetes Diagnostics Market Report Sample Now:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Is the Expected Market Size of Diabetes Diagnostics by 2029?
Expectations are high for a significant surge in the diabetes diagnostics market in the near future, with a predicted growth to a market size of $36.72 billion by 2029 at a compounded annual growth rate (CAGR) of 7.6%. This growth can be linked to a variety of factors such as the rise in the use of insulin pumps, steady advances in diabetic technology, a growing tendency towards unhealthy lifestyles, an increase in the occurrence of type 1 and type 2 diabetes, and a burgeoning healthcare infrastructure. Looking forward, the marketplace will see trends such as enhancements in biosensor technology, medical advancements, breakthroughs in diagnostic technologies, emphasis on customized medicine and targeted treatments, and developments in in vitro diagnostic product technology.
Access The Full Report Today!
http://www.thebusinessresearchcompany.com/purchas…x?id=21167
What Are the Key Drivers Shaping the Diabetes Diagnostics Market Landscape?
The escalation in obesity rates is predicted to drive the expansion of the diabetes diagnostics market in the future. Obesity, characterized by excessive fat accumulation in the body, heightens the risk of numerous health issues, such as heart ailments and diabetes. This increased incidence of obesity stems from factors like inactive lifestyle, augmented intake of high-calorie and processed food, genetic susceptibility, and minimal physical exercise.
Diabetes diagnostics help manage obesity by promptly recognizing issues related to insulin resistance and glucose metabolism, thus allowing timely interventions to prevent weight increase and related health issues. For example, as per the Centers for Disease Control and Prevention, a government agency based in the US, in September 2023, in 2022, 22 states recorded an adult obesity rate of 35% or above, reflecting an increase from 19 states in 2021. Consequently, this higher prevalence of obesity is spurring the growth of the diabetes diagnostics market.
Looking for something specific? Request customization here –
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Who Are the Market Leaders in Diabetes Diagnostics Innovation and Development?
Major companies operating in the diabetes diagnostics market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Novartis AG, 3M Company, Medtronic plc, Regeneron Pharmaceuticals Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, DexCom Inc, Santen Pharmaceutical Co. Ltd., Topcon Corporation, Tandem Diabetes Care Inc, Ypsomed AG, LifeScan Inc, Nova Biomedical Corporation, Ascensia Diabetes Care Holdings AG, ARKRAY Inc, Optos plc, Bioland Technology Ltd, PTS Diagnostics Inc, AgaMatrix Inc, Senseonics Holdings Inc, DarioHealth Corp.
What Are the Most Promising Segments in the Diabetes Diagnostics Market?
The diabetes diagnostics market covered in this report is segmented –
1) By Product Type: Blood Glucose Meters, Continuous Glucose Monitoring Devices, Lancets, Test Strips, Other Product Types
2) By Diabetes Type: Diabetes I, Diabetes II, Gestational Diabetes
3) By End-User: Hospitals, Diagnostic Centers, Homecare Settings, Other End-Users
Subsegments:
1) By Blood Glucose Meters: Traditional Blood Glucose Meters, Smart Blood Glucose Meters, Bluetooth-enabled Blood Glucose Meters
2) By Continuous Glucose Monitoring Devices: Wearable CGM Systems, Implantable CGM Systems, Flash Glucose Monitoring Devices
3) By Lancets: Single-use Lancets, Multi-use Lancets
4) By Test Strips: Standard Test Strips, Smart Test Strips
5) By Other Product Types: Hemoglobin A1c Testing Kits, Urine Glucose Test Strips, Blood Ketone Meters
Maximize Your Market Potential – Get The Complete Report Now!
http://www.thebusinessresearchcompany.com/report/…ket-report
What Critical Trends Are Likely to Reshape Consumer Preferences in the Diabetes Diagnostics Market?
Major players in the diabetes diagnostics market aim to broaden their product range and cater to the increasing need for early diagnosis and management of diabetes during pregnancy by innovating products such as gestational diabetes diagnostics tools. Gestational diabetes diagnostic tools are medical devices or tests that are specifically used to identify and track gestational diabetes in expectant mothers, often employing blood glucose tests like the oral glucose tolerance test (OGTT) to determine how effectively sugar is processed during pregnancy. For example, DirectSens GmbH, a biotech firm based in Austria, introduced the XpressGT RUO kit in August 2024. This revolutionary biosensor tool was crafted to identify conditions linked to insulin resistance, such as gestational diabetes, endometriosis, and liver disease. The kit has the ability to deliver quick results by measuring 2-hydroxybutyrate (2-HB) levels in venous blood, and it can be used in conjunction with standard clinical analyzers. This innovative approach aims to provide early diagnosis, thereby potentially bettering the prognosis for millions of patients globally.
Which Regions Are Emerging as Key Players in the Global Diabetes Diagnostics Market?
North America was the largest region in the diabetes diagnostics market in 2024. The regions covered in the diabetes diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Questions Addressed In This Report:
1.What is the revenue and growth projection for the diabetes diagnostics market?
2.What factors are driving diabetes diagnostics market growth, globally?
3.Which segment accounted for the largest diabetes diagnostics market share?
4.Who are the top companies operating in the diabetes diagnostics market?
5.Which region is projected to witness the fastest growth during the forecast period?
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
For more information:
http://www.thebusinessresearchcompany.com/report/…ket-report
